Wragge Lawrence Graham & Co
- Company/Commercial (53)
- Corporate (47)
- Real Estate (32)
- Banking / Finance (26)
- Funds (26)
- Intellectual Property (18)
- Litigation / Dispute Resolution (18)
- Employment (17)
- Information Technology (16)
- Energy (14)
- Tax (14)
- Financial services (13)
- Construction (12)
- PPP/PFI/Commercial projects (12)
- Public Sector/Local Authority (9)
- Regulatory and compliance (9)
- Pensions (8)
- Pharma/Biotech (8)
- Private Equity (8)
- Telecoms (8)
- Planning (7)
- Competition/EU (6)
- Private Client (6)
- Environment (4)
- Healthcare (4)
- Personal tax / Trusts (4)
- Business Tax (3)
- Insurance/reinsurance (3)
- Media/Entertainment/Sport (3)
- Charities (2)
- Family (2)
- Human Rights (2)
- Insolvency & restructuring (2)
- Transport (Including aviation and shipping) (2)
- Travel and Tourism (2)
- Commodities (1)
- Immigration (1)
- In-House (1)
- Licensing/Gaming/Betting (1)
- Other (1)
- Sovereign Wealth (1)
Sort By: Newest first | Oldest first
Wragge Lawrence Graham & Co has advised Africa Growth and Energy Services on the drafting of a series of project documents to support a landmark renewable project in Sierra Leone.
Wragge Lawrence Graham & Co is one of the UK’s Best Workplaces, according to the Great Place to Work Institute’s annual Best Workplaces list.
Wragge Lawrence Graham & Co’s pensions team has been appointed as main legal adviser to the trustees of the £76,875,000 Fujitsu Pension Scheme.
Wragge Lawrence Graham & Co’s corporate team has acted for Gigaclear plc on a £30m investment to expand its provision of ultrafast fibre-to-the-premises networks to rural communities.
Wragge Lawrence Graham & Co has advised AstraZeneca on a co-development and commercialisation agreement with Innate Pharma SA, a biopharmaceutical company developing therapeutic antibodies for the treatment of cancer.
Wragge Lawrence Graham & Co’s investment funds team has advised AEW UK REIT Plc on a fundraising worth £100m.
The cross-sector energy team at Wragge Lawrence Graham & Co has advised established client Grid Essence on the sale of a portfolio of eight solar PV parks and the subsequent refinancing of the projects.
David Fennell, CEO of Wragge Lawrence Graham & Co, has been ranked number 72 in Business Insider’s annual ‘Power People’ list.
Wragge Lawrence Graham & Co has advised AIM-traded Staffline on its £34.5m acquisition of A4e Ltd, creating one of the UK’s largest Work Programme providers.
Wragge Lawrence Graham & Co’s tech team has helped new client Breezie to secure investment from the Ziegler LinkAge Longevity Fund.
Wragge Lawrence Graham & Co has promoted six new partners, enhancing its capability in corporate, energy, dispute resolution and real estate.
Wragge Lawrence Graham & Co has strengthened its offering in Dubai with the arrival of Jonathan Brufal, an energy and infrastructure projects partner.
Wragge Lawrence Graham & Co’s banking and finance team have advised the North West Evergreen Fund on its £15m investment to Allied London to part-fund the development of No.1 Spinningfields in Manchester.
A team from the banking and finance department has advised Harworth Estates Property Group on the refinancing of its group banking facilities.
The Energy & Infrastructure Finance team at Wragge Lawrence Graham & Co has advised Ecotricity on the refinancing of a portfolio of 19 operational wind and solar assets worth £70m.
A five-strong public law team has joined Wragge Lawrence Graham & Co’s Paris office.
Wragge Lawrence Graham & Co’s investment funds team has advised Empiric Student Property plc on an £85m fund raising, exceeding its target of approximately £75m.
In the past two months Wragge Lawrence Graham & Co’s corporate team has acted for two special purpose acquisition companies on admission to the UK Listing Authority’s Official List and to the London Stock Exchange’s main market.
Wragge Lawrence Graham & Co’s corporate team has advised longstanding client and AIM-quoted Ambrian plc on its merger with Consolidated General Minerals plc (CGM).
Wragges has advised long-standing client on a three-year drug discovery collaboration agreement with Orca.